Bayer | BAYN - Ordinary Share Capital


Bayer reported EUR982.42M in Ordinary Share Capital for its fiscal quarter ending in December of 2025.





Ordinary Share Capital Change Date
Air Liquide EUR 577.57M 2.6B Dec/2025
Akzo Nobel EUR 171.11M 0 Dec/2025
Alcon AG USD 487.4M 7.2M Dec/2025
Amarin USD 20.81M 13K Dec/2025
Arkema EUR 75.64M 375K Dec/2025
AstraZeneca USD 1.55B 206K Dec/2025
BASF EUR 892.52M 249.48M Sep/2025
Bayer EUR 982.42M 0 Dec/2025
Beiersdorf EUR 218.92M 1.29M Dec/2025
Corteva USD 672.16M 4.59M Dec/2025
Covestro EUR 207.64M 18.9M Dec/2025
Essilor EUR 463.05M 1.9M Dec/2025
Fresenius EUR 563.24M 0 Sep/2025
Fresenius Medical Care EUR 279.29M 10.56M Dec/2025
Genmab DKK 61.62M 52K Dec/2025
Givaudan CHF 9.23M 0 Dec/2025
GlaxoSmithKline GBP 4.08B 49.43M Dec/2025
GRIFOLS EUR 680.58M 846K Dec/2025
Henkel EUR 406.79M 7.18M Dec/2025
Hikma Pharmaceutical USD 221.89M 181.89M Dec/2025
Johnson Matthey GBP 168.06M 217K Dec/2025
Linde USD 463.68M 3.27M Dec/2025
Lonza CHF 68.64M 0 Dec/2025
Merck EUR 434.78M 0 Dec/2025
Novartis USD 1.91B 10.64M Dec/2025
Nutrien USD 481.96M 2.37M Dec/2025
Philips EUR 951.29M 310K Dec/2025
PPG Industries USD 224.4M 1.3M Sep/2025
Roche Holding CHF 795.62M 699.54K Dec/2025
SAP EUR 1.17B 86K Dec/2025
Solvay EUR 104.46M 0 Dec/2025
UCB EUR 190.36M 365.15K Dec/2025
Umicore EUR 240.56M 1.14B Dec/2025
Vinci EUR 559.63M 895.37M Jun/2025